The Hamoui Foundation/LUNGevity Award for RET-Positive Lung Cancer Research supports high-impact research that seeks to transform the future for people diagnosed with RET-positive lung cancer by changing RET-positive lung cancer into a chronic or curable condition.
At the start of the award term, an applicant must:
- Hold a doctoral degree
- Have a faculty appointment with a university-based academic institution or a research institution that is not formally associated with a university
An applicant may be at any level of research experience.
The goal of the award is to fund impactful proposals in the RET-positive lung cancer space with direct clinical implications within 1-2 years. Projects must be directly related to improvement of patient outcomes and ideally lead to a clinical trial (if the project itself does not include a clinical trial).
The Hamoui Foundation/LUNGevity Awards may be for a maximum of $1,000,000
- $500,000 per year for 2 years
- Six-month milestones must be met
Note: Only one The Hamoui Foundation/LUNGevity Award will be granted per institution.